RecruitingNot ApplicableNCT07268261

Combined Method of Surgical Treatment of Anal Fissure


Sponsor

State Scientific Centre of Coloproctology, Russian Federation

Enrollment

122 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to improve treatment outcomes for patients with chronic anal fissure.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria1

  • Patients with chronic anal fissure with spasm of anal sphincter

Exclusion Criteria13

  • Inflammatory diseases of the colon
  • Pectenosis
  • Previous surgical interventions on the anal canal
  • IV grade internal and external hemorrhoids
  • Rectal fistula
  • Severe somatic diseases at the decompensation stage
  • Pregnancy and lactation
  • Anal sphincter insufficiency
  • Chronic paraproctitis
  • Individual intolerance and hypersensitivity to botulinum toxin
  • Myasthenia gravis and myasthenic syndromes
  • History of allergic reaction to anticoagulants.
  • Blood diseases (thrombocytopenia, splenomegaly, etc.)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREexcision of the anal fissure with further relaxation of the internal sphincter with botulinum toxin A

patients undergo excision of the fissure in combination with drug relaxation of the internal sphincter with botulinum toxin type A at a dosage of 40 units of action; an additional injection of platelet-rich plasma is added


Locations(1)

SSCCRussia

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07268261


Related Trials